Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports

Share Article

The conference will address the progress of Tylenol lawsuits filed on behalf of individuals who sustained serious liver damage injuries that resulted in hospitalization, the need for a transplant or death, allegedly due to acetaminophen in Tylenol products.

Free Case Review
As our Firm continues to hear from individuals who allege liver damage caused by Tylenol, we are looking forward to the federal litigation’s upcoming status conference next month.

Tylenol lawsuits (http://www.tylenollawsuitcenter.com/) filed on behalf of individuals who were allegedly injured by the medication are continuing to move forward in Pennsylvania federal court, where a federal litigation is looking ahead to a status conference in December, Bernstein Liebhard LLP reports.

According to a Scheduling Order issued earlier this year, a conference in the Tylenol proceeding will take place on December 16th at 10:00 a.m. Items likely to be discussed at the meeting include lawsuits that allege liver damage injuries caused by the pain reliever’s active ingredient, acetaminophen. Complications may have resulted in hospitalization, the need for a transplant or even death, plaintiffs allege. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

“As our Firm continues to hear from individuals who allege liver damage caused by Tylenol, we are looking forward to the federal litigation’s upcoming status conference next month,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs including Tylenol. The Firm is offering free and legal evaluations to individuals who were allegedly harmed by an over-the-counter Tylenol product.

Tylenol Liver Damage Litigation
Court documents show 163 Tylenol liver damage lawsuits now pending in the Eastern District of Pennsylvania, after being filed by people who accuse Johnson & Johnson and McNeil Consumer Healthcare of failing to adequately warn consumers about the alleged risks of acetaminophen, even when medications are taken in accordance with label directions.

An investigation led by Consumer Reports recently lent evidence to the frequency of acetaminophen injuries, finding that 80,000 people are sent to the emergency room each year because of complications caused by the active Tylenol ingredient. Even if just for a few days, the probe also found that exceeding 4,000 milligram daily dosages of acetaminophen for just a few days can lead to liver damage and other complications. The daily limits recommended for many over-the-counter medications are often very close to that amount, however, Consumer Reports noted.*

In January, the U.S. Food and Drug Administration (FDA) finalized new guidance for acetaminophen amounts in prescription medications, which do not apply to over-the-counter Tylenol products. Caplets should each contain no more than 325 milligrams of acetaminophen, the regulations stated.

A Bloomberg.com report published in August 2013 reported that over-the-counter Extra Strength Tylenol pills contain 500 milligrams of the ingredient, significantly more than the FDA-recommended amount for prescription medications.**

Victims of acetaminophen-induced liver damage allegedly linked to a Tylenol-brand medication may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. Learn more about filing a Tylenol lawsuit by visiting Bernstein Liebhard LLP’s website. Free, confidential and no-obligation case reviews are available by calling 800-511-5092.

*newsnet5.com/money/consumer/consumer-specialist/warning-about-acetaminophen-consumer-reports-investigates, Consumer Reports (via 5 ABC News) October 29, 2014
**bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website